Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

In vitro growth inhibition of Theileria equi by bumped kinase inhibitors.

Gimenez F, Hines SA, Evanoff R, Ojo KK, Van Voorhis WC, Maly DJ, Vidadala RSR, Mealey RH.

Vet Parasitol. 2018 Feb 15;251:90-94. doi: 10.1016/j.vetpar.2017.12.024. Epub 2018 Jan 1.

2.

Modeling Rabbit Responses to Single and Multiple Aerosol Exposures of Bacillus anthracis Spores.

Coleman ME, Marks HM, Bartrand TA, Donahue DW, Hines SA, Comer JE, Taft SC.

Risk Anal. 2017 May;37(5):943-957. doi: 10.1111/risa.12688. Epub 2017 Jan 25.

3.

Theileria equi isolates vary in susceptibility to imidocarb dipropionate but demonstrate uniform in vitro susceptibility to a bumped kinase inhibitor.

Hines SA, Ramsay JD, Kappmeyer LS, Lau AO, Ojo KK, Van Voorhis WC, Knowles DP, Mealey RH.

Parasit Vectors. 2015 Jan 20;8:33. doi: 10.1186/s13071-014-0611-6.

4.

In contrast to other species, α-Galactosylceramide (α-GalCer) is not an immunostimulatory NKT cell agonist in horses.

Dossa RG, Alperin DC, Garzon D, Mealey RH, Brown WC, Jervis PJ, Besra GS, Cox LR, Hines SA.

Dev Comp Immunol. 2015 Mar;49(1):49-58. doi: 10.1016/j.dci.2014.11.005. Epub 2014 Nov 10.

PMID:
25445911
5.

A Weekly Spark for Progressive Educators: Annie Murphy Paul's Brilliant Blog and Newsletter.

Hines SA.

J Microbiol Biol Educ. 2014 May 1;15(1):63-4. doi: 10.1128/jmbe.v15i1.716. eCollection 2014 May. Review. No abstract available.

6.

Assessment of relative potential for Legionella species or surrogates inhalation exposure from common water uses.

Hines SA, Chappie DJ, Lordo RA, Miller BD, Janke RJ, Lindquist HA, Fox KR, Ernst HS, Taft SC.

Water Res. 2014 Jun 1;56:203-13. doi: 10.1016/j.watres.2014.02.013. Epub 2014 Feb 26.

PMID:
24681377
7.

The equine CD1 gene family is the largest and most diverse yet identified.

Dossa RG, Alperin DC, Hines MT, Hines SA.

Immunogenetics. 2014 Jan;66(1):33-42. doi: 10.1007/s00251-013-0741-6. Epub 2013 Nov 7.

PMID:
24196432
8.

Rhodococcus equi research 2008-2012: report of the Fifth International Havemeyer Workshop.

Cauchard S, Giguère S, Venner M, Muscatello G, Cauchard J, Cohen ND, Haas A, Hines SA, Hondalus MK, Horohov DW, Meijer WG, Prescott JF, Vázquez-Boland J.

Equine Vet J. 2013 Sep;45(5):523-6. doi: 10.1111/evj.12103. No abstract available.

PMID:
23909447
9.

Benchmark dose analysis for Bacillus anthracis inhalation exposures in the nonhuman primate.

Taft SC, Hines SA.

Risk Anal. 2012 Oct;32(10):1750-68. doi: 10.1111/j.1539-6924.2012.01808.x. Epub 2012 Apr 1. Review.

PMID:
22469218
10.

Rhodococcus equi: clinical manifestations, virulence, and immunity.

Giguère S, Cohen ND, Chaffin MK, Hines SA, Hondalus MK, Prescott JF, Slovis NM.

J Vet Intern Med. 2011 Nov-Dec;25(6):1221-30. doi: 10.1111/j.1939-1676.2011.00804.x. Epub 2011 Oct 7. Review.

11.

Diagnosis, treatment, control, and prevention of infections caused by Rhodococcus equi in foals.

Giguère S, Cohen ND, Chaffin MK, Slovis NM, Hondalus MK, Hines SA, Prescott JF.

J Vet Intern Med. 2011 Nov-Dec;25(6):1209-20. doi: 10.1111/j.1939-1676.2011.00835.x. Epub 2011 Nov 1.

12.

Early development of cytotoxic T lymphocytes in neonatal foals following oral inoculation with Rhodococcus equi.

Harris SP, Hines MT, Mealey RH, Alperin DC, Hines SA.

Vet Immunol Immunopathol. 2011 Jun 15;141(3-4):312-6. doi: 10.1016/j.vetimm.2011.03.015. Epub 2011 Mar 21.

13.

Identification of Rhodococcus equi lipids recognized by host cytotoxic T lymphocytes.

Harris SP, Fujiwara N, Mealey RH, Alperin DC, Naka T, Goda R, Hines SA.

Microbiology. 2010 Jun;156(Pt 6):1836-47. doi: 10.1099/mic.0.035915-0. Epub 2010 Mar 18.

14.

Rhodococcus equi comes of age.

Vazquez-Boland JA, Prescott JF, Meijer WG, Leadon DP, Hines SA.

Equine Vet J. 2009 Jan;41(1):93-5. No abstract available.

PMID:
19301589
15.

The influence of age and Rhodococcus equi infection on CD1 expression by equine antigen presenting cells.

Pargass IS, Wills TB, Davis WC, Wardrop KJ, Alperin DC, Hines SA.

Vet Immunol Immunopathol. 2009 Aug 15;130(3-4):197-209. doi: 10.1016/j.vetimm.2009.02.007. Epub 2009 Feb 14.

PMID:
19285733
16.

Serum antibodies against human albumin in critically ill and healthy dogs.

Martin LG, Luther TY, Alperin DC, Gay JM, Hines SA.

J Am Vet Med Assoc. 2008 Apr 1;232(7):1004-9. doi: 10.2460/javma.232.7.1004.

PMID:
18380616
17.

Experimental Rhodococcus equi and equine infectious anemia virus DNA vaccination in adult and neonatal horses: effect of IL-12, dose, and route.

Mealey RH, Stone DM, Hines MT, Alperin DC, Littke MH, Leib SR, Leach SE, Hines SA.

Vaccine. 2007 Oct 23;25(43):7582-97. Epub 2007 Aug 15.

18.

Adverse reactions suggestive of type III hypersensitivity in six healthy dogs given human albumin.

Francis AH, Martin LG, Haldorson GJ, Lahmers KK, Luther TY, Alperin DC, Hines SA.

J Am Vet Med Assoc. 2007 Mar 15;230(6):873-9.

PMID:
17362162
19.

The Babesia bovis merozoite surface antigen 1 hypervariable region induces surface-reactive antibodies that block merozoite invasion.

LeRoith T, Berens SJ, Brayton KA, Hines SA, Brown WC, Norimine J, McElwain TF.

Infect Immun. 2006 Jun;74(6):3663-7.

20.

Development of specific immunoglobulin Ga (IgGa) and IgGb antibodies correlates with control of parasitemia in Babesia equi Infection.

Cunha CW, McGuire TC, Kappmeyer LS, Hines SA, Lopez AM, Dellagostin OA, Knowles DP.

Clin Vaccine Immunol. 2006 Feb;13(2):297-300.

21.
22.

The Student Progress Committee: a proactive approach to academic excellence in an age of accountability.

Burns GA, Hines SA, Wardrop KJ.

J Vet Med Educ. 2005 Summer;32(2):219-22. No abstract available.

PMID:
16078174
23.

ATLes: the strategic application of Web-based technology to address learning objectives and enhance classroom discussion in a veterinary pathology course.

Hines SA, Collins PL, Quitadamo IJ, Brahler CJ, Knudson CD, Crouch GJ.

J Vet Med Educ. 2005 Spring;32(1):103-12.

PMID:
15834828
24.

Rhodococcus equi-specific cytotoxic T lymphocytes in immune horses and development in asymptomatic foals.

Patton KM, McGuire TC, Hines MT, Mealey RH, Hines SA.

Infect Immun. 2005 Apr;73(4):2083-93.

26.

Rhodococcus equi secreted antigens are immunogenic and stimulate a type 1 recall response in the lungs of horses immune to R. equi infection.

Kohler AK, Stone DM, Hines MT, Byrne BA, Alperin DC, Norton LK, Hines SA.

Infect Immun. 2003 Nov;71(11):6329-37.

27.

Analysis of anamnestic immune responses in adult horses and priming in neonates induced by a DNA vaccine expressing the vapA gene of Rhodococcus equi.

Lopez AM, Hines MT, Palmer GH, Knowles DP, Alperin DC, Hines SA.

Vaccine. 2003 Sep 8;21(25-26):3815-25.

PMID:
12922115
28.

Organization, transcription, and expression of rhoptry associated protein genes in the Babesia bigemina rap-1 locus.

Suarez CE, Palmer GH, Florin-Christensen M, Hines SA, Hötzel I, McElwain TF.

Mol Biochem Parasitol. 2003 Apr 3;127(2):101-12.

PMID:
12672519
29.

Clearance of virulent but not avirulent Rhodococcus equi from the lungs of adult horses is associated with intracytoplasmic gamma interferon production by CD4+ and CD8+ T lymphocytes.

Hines SA, Stone DM, Hines MT, Alperin DC, Knowles DP, Norton LK, Hamilton MJ, Davis WC, McGuire TC.

Clin Diagn Lab Immunol. 2003 Mar;10(2):208-15.

30.

Identification of pulmonary T-lymphocyte and serum antibody isotype responses associated with protection against Rhodococcus equi.

Lopez AM, Hines MT, Palmer GH, Alperin DC, Hines SA.

Clin Diagn Lab Immunol. 2002 Nov;9(6):1270-6.

31.

The Babesia bovis merozoite surface antigen 2 locus contains four tandemly arranged and expressed genes encoding immunologically distinct proteins.

Florin-Christensen M, Suarez CE, Hines SA, Palmer GH, Brown WC, McElwain TF.

Infect Immun. 2002 Jul;70(7):3566-75.

32.

Immunity to Rhodococcus equi: antigen-specific recall responses in the lungs of adult horses.

Hines MT, Paasch KM, Alperin DC, Palmer GH, Westhoff NC, Hines SA.

Vet Immunol Immunopathol. 2001 May 10;79(1-2):101-14.

PMID:
11356253
33.

Virulence plasmid of Rhodococcus equi contains inducible gene family encoding secreted proteins.

Byrne BA, Prescott JF, Palmer GH, Takai S, Nicholson VM, Alperin DC, Hines SA.

Infect Immun. 2001 Feb;69(2):650-6.

34.
35.

DNA sequence and comparison of virulence plasmids from Rhodococcus equi ATCC 33701 and 103.

Takai S, Hines SA, Sekizaki T, Nicholson VM, Alperin DA, Osaki M, Takamatsu D, Nakamura M, Suzuki K, Ogino N, Kakuda T, Dan H, Prescott JF.

Infect Immun. 2000 Dec;68(12):6840-7.

36.

Phosphatidylcholine formation is the predominant lipid biosynthetic event in the hemoparasite Babesia bovis.

Florin-Christensen J, Suarez CE, Florin-Christensen M, Hines SA, McElwain TF, Palmer GH.

Mol Biochem Parasitol. 2000 Feb 25;106(1):147-56.

PMID:
10743618
37.

Detection of equine antibodies to babesia caballi by recombinant B. caballi rhoptry-associated protein 1 in a competitive-inhibition enzyme-linked immunosorbent assay.

Kappmeyer LS, Perryman LE, Hines SA, Baszler TV, Katz JB, Hennager SG, Knowles DP.

J Clin Microbiol. 1999 Jul;37(7):2285-90.

38.

Sequence and functional analysis of the intergenic regions separating babesial rhoptry-associated protein-1 (rap-1) genes.

Suarez CE, Palmer GH, Hötzel I, Hines SA, McElwain TF.

Exp Parasitol. 1998 Oct;90(2):189-94.

PMID:
9769249
39.

VapA-negative Rhodococcus equi in a dog with necrotizing pyogranulomatous hepatitis, osteomyelitis, and myositis.

Cantor GH, Byrne BA, Hines SA, Richards HM 3rd.

J Vet Diagn Invest. 1998 Jul;10(3):297-300. No abstract available.

PMID:
9683085
40.

In vivo binding of immunoglobulin M to the surfaces of Babesia bigemina-infected erythrocytes.

Echaide IE, Hines SA, McElwain TF, Suarez CE, McGuire TC, Palmer GH.

Infect Immun. 1998 Jun;66(6):2922-7.

41.
42.

Immunity to Rhodococcus equi.

Hines SA, Kanaly ST, Byrne BA, Palmer GH.

Vet Microbiol. 1997 Jun 16;56(3-4):177-85. Review.

PMID:
9226832
43.

Rhodococcal pneumonia: humoral versus cell-mediated immunity.

Hines SA, Hietala SK.

Equine Vet J. 1996 Sep;28(5):339-40. No abstract available.

PMID:
8894528
44.
45.
46.

Genetic and antigenic characterization of Babesia bovis merozoite spherical body protein Bb-1.

Hines SA, Palmer GH, Brown WC, McElwain TF, Suarez CE, Vidotto O, Rice-Ficht AC.

Mol Biochem Parasitol. 1995 Feb;69(2):149-59.

PMID:
7770080
47.

Immunization of cattle with recombinant Babesia bovis merozoite surface antigen-1.

Hines SA, Palmer GH, Jasmer DP, Goff WL, McElwain TF.

Infect Immun. 1995 Jan;63(1):349-52.

48.

Identification of Babesia bigemina infected erythrocyte surface antigens containing epitopes conserved among strains.

Shompole S, McElwain TF, Jasmer DP, Hines SA, Katende J, Musoke AJ, Rurangirwa FR, McGuire TC.

Parasite Immunol. 1994 Mar;16(3):119-27.

PMID:
8208585
49.

Conservation of oligopeptide motifs in rhoptry proteins from different genera of erythroparasitic protozoa.

Suarez CE, Thompson SM, McElwain TF, Hines SA, Palmer GH.

Exp Parasitol. 1994 Mar;78(2):246-51. No abstract available.

PMID:
8119378
50.

Babesia bigemina: isolation and characterization of merozoite rhoptries.

Machado RZ, McElwain TF, Suarez CE, Hines SA, Palmer GH.

Exp Parasitol. 1993 Nov;77(3):315-25.

PMID:
8224087

Supplemental Content

Loading ...
Support Center